- Home
- LULU vs TEVA Comparison
LULU vs TEVA Comparison
Compare LULU & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LULU
- TEVA
- Stock Information
- Founded
- LULU 1998
- TEVA 1901
- Country
- LULU Canada
- TEVA Israel
- Employees
- LULU N/A
- TEVA N/A
- Industry
- LULU Apparel
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- LULU Consumer Discretionary
- TEVA Health Care
- Exchange
- LULU Nasdaq
- TEVA Nasdaq
- Market Cap
- LULU 19.9B
- TEVA 21.2B
- IPO Year
- LULU 2007
- TEVA N/A
- Fundamental
- Price
- LULU $166.28
- TEVA $24.02
- Analyst Decision
- LULU Hold
- TEVA Strong Buy
- Analyst Count
- LULU 28
- TEVA 7
- Target Price
- LULU $229.69
- TEVA $25.86
- AVG Volume (30 Days)
- LULU 3.9M
- TEVA 12.0M
- Earning Date
- LULU 12-04-2025
- TEVA 11-05-2025
- Dividend Yield
- LULU N/A
- TEVA N/A
- EPS Growth
- LULU 13.74
- TEVA N/A
- EPS
- LULU 14.72
- TEVA 0.62
- Revenue
- LULU $10,904,036,000.00
- TEVA $16,776,000,000.00
- Revenue This Year
- LULU $5.63
- TEVA $4.11
- Revenue Next Year
- LULU $4.51
- TEVA $0.40
- P/E Ratio
- LULU $11.28
- TEVA $39.64
- Revenue Growth
- LULU 9.16
- TEVA 0.02
- 52 Week Low
- LULU $159.25
- TEVA $12.47
- 52 Week High
- LULU $423.32
- TEVA $25.00
- Technical
- Relative Strength Index (RSI)
- LULU 44.34
- TEVA 76.02
- Support Level
- LULU $160.46
- TEVA $20.11
- Resistance Level
- LULU $169.74
- TEVA $25.00
- Average True Range (ATR)
- LULU 6.10
- TEVA 0.70
- MACD
- LULU -0.77
- TEVA 0.50
- Stochastic Oscillator
- LULU 22.00
- TEVA 83.00
About LULU lululemon athletica inc.
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 780 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 40 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.